As we have previously reported, the use of Pradaxa has been linked to serious injury. There are nearly 600 cases currently pending in federal court. The lawsuits allege that Pradaxa, manufactured by Boehringer Ingelheim, Inc., has resulted in devastating and sometimes fatal outcomes. Pradaxa is a blood thinner that was marketed to replace warfarin, a commonly used anticoagulant. Unfortunately, there is no readily-available antidote for the internal bleeding that can sometimes occur in patients treated with Pradaxa.
The maker of the drug, Boehringer Ingelheim, recently updated label warnings of Pradaxa to include the risk of a blood platelet disorder. The label warns of an increased risk of thrombocytopenia, a drop in blood platelets that can cause internal bleeding. Many of the current individuals involved in the Pradaxa litigation have experienced internal bleeding. You can read the updated label warning here.
The devastating consequences of Pradaxa use will likely continue. If you or a loved one has experienced serious side effects after taking Pradaxa, you can contact Stark & Stark and speak to one of the Mass Tort attorneys, free of charge, who can help assess any claims that you might have against Boehringer Ingelheim Pharmaceuticals, Inc.